Sökning: WFRF:(Benediktsdottir Bryndis) >
Nocturnal sweating ...
-
Arnardottir, Erna Sif
(författare)
Nocturnal sweating - a common symptom of obstructive sleep apnoea : the Icelandic sleep apnoea cohort
- Artikel/kapitelEngelska2013
Förlag, utgivningsår, omfång ...
-
2013-05-14
-
BMJ,2013
-
electronicrdacarrier
Nummerbeteckningar
-
LIBRIS-ID:oai:DiVA.org:uu-220570
-
https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-220570URI
-
https://doi.org/10.1136/bmjopen-2013-002795DOI
Kompletterande språkuppgifter
-
Språk:engelska
-
Sammanfattning på:engelska
Ingår i deldatabas
Klassifikation
-
Ämneskategori:ref swepub-contenttype
-
Ämneskategori:art swepub-publicationtype
Anmärkningar
-
Objectives: To estimate the prevalence and characteristics of frequent nocturnal sweating in obstructive sleep apnoea (OSA) patients compared with the general population and evaluate the possible changes with positive airway pressure (PAP) treatment. Nocturnal sweating can be very bothersome to the patient and bed partner. Design: Case-control and longitudinal cohort study. Setting: Landspitali-The National University Hospital, Iceland. Participants: The Icelandic Sleep Apnea Cohort consisted of 822 untreated patients with OSA, referred for treatment with PAP. Of these, 700 patients were also assessed at a 2-year follow-up. The control group consisted of 703 randomly selected subjects from the general population. Intervention: PAP therapy in the OSA cohort. Main outcome measures: Subjective reporting of nocturnal sweating on a frequency scale of 1-5: (1) never or very seldom, (2) less than once a week, (3) once to twice a week, (4) 3-5 times a week and (5) every night or almost every night. Full PAP treatment was defined objectively as the use for = 4 h/day and = 5 days/week. Results: Frequent nocturnal sweating (= 3x a week) was reported by 30.6% of male and 33.3% of female OSA patients compared with 9.3% of men and 12.4% of women in the general population (p<0.001). This difference remained significant after adjustment for demographic factors. Nocturnal sweating was related to younger age, cardiovascular disease, hypertension, sleepiness and insomnia symptoms. The prevalence of frequent nocturnal sweating decreased with full PAP treatment (from 33.2% to 11.5%, p<0.003 compared with the change in non-users). Conclusions: The prevalence of frequent nocturnal sweating was threefold higher in untreated OSA patients than in the general population and decreased to general population levels with successful PAP therapy. Practitioners should consider the possibility of OSA in their patients who complain of nocturnal sweating.
Biuppslag (personer, institutioner, konferenser, titlar ...)
-
Janson, ChristerUppsala universitet,Lungmedicin och allergologi(Swepub:uu)chrisjn
(författare)
-
Bjornsdottir, Erla
(författare)
-
Benediktsdottir, Bryndis
(författare)
-
Juliusson, Sigurdur
(författare)
-
Kuna, Samuel T.
(författare)
-
Pack, Allan I.
(författare)
-
Gislason, Thorarinn
(författare)
-
Uppsala universitetLungmedicin och allergologi
(creator_code:org_t)
Sammanhörande titlar
-
Ingår i:BMJ Open: BMJ3:5, s. e002795-2044-6055
Internetlänk
Hitta via bibliotek
-
BMJ Open
(Sök värdpublikationen i LIBRIS)
Till lärosätets databas